Versions Compared

Key

  • This line was added.
  • This line was removed.
  • Formatting was changed.

This example illustrates data from an AE CRF that collected AE terms as free text. AEs were coded using MedDRA, and the sponsor’s procedures include the possibility of modifying the reported term to aid in coding. The CRF was structured so that seriousness category variables (e.g., AESDTH, AESHOSP) were checked only when AESER is answered “Y.” In this study, the study reference period started at the start of study treatment. Three AEs were reported for this subject.

Dataset wrap
Rowcaps
Rows 1-2:Show examples of modifying the reported term for coding purposes, with the modified term in AEMODIFY. These adverse events were not serious, so the seriousness criteria variables are null. Note that for the event in row 2, AESTDY = "1". Day 1 was the day treatment started; the AE start and end times, as well as dates, were collected to allow comparison of the AE timing to the start of treatment.
Row 3:Shows an example of the overall seriousness question AESER answered with "Y" and the relevant corresponding seriousness category variables (AESHOSP and AESLIFE) answered "Y". The other seriousness category variables are left blank. This row also shows AEENRF being populated because the AE was marked as “Continuing” as of the end of the study reference period for the subject (see Section 4.4.7, Use of Relative Timing Variables).
Dataset2
RowSTUDYIDDOMAINUSUBJIDAESEQAETERMAEMODIFYAEDECODAEBODSYSAESEVAESERAEACNAERELAEOUTAESCONGAESDISABAESDTHAESHOSPAESLIFEAESMIEEPOCHAESTDTCAEENDTCAESTDYAEENDYAEENRF
1ABC123AE1231011POUNDING HEADACHEHEADACHEHeadacheNervous system disordersSEVERENNOT APPLICABLEDEFINITELY NOT RELATEDRECOVERED/RESOLVED





SCREENING2005-10-122005-10-12-1-1
2ABC123AE1231012BACK PAIN FOR 6 HOURSBACK PAINBack painMusculoskeletal and connective tissue disordersMODERATENDOSE REDUCEDPROBABLY RELATEDRECOVERED/RESOLVED





TREATMENT2005-10-13T13:052005-10-13T19:0011
3ABC123AE1231013PULMONARY EMBOLISM
Pulmonary embolismVascular disordersMODERATEYDOSE REDUCEDPROBABLY NOT RELATEDRECOVERING/RESOLVING


YY
TREATMENT2005-10-21
9
AFTER